Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Aurobindo Pharma in focus on launch of generic version of Sensipar tablets in US

      Aurobindo Pharma in focus on launch of generic version of Sensipar tablets in US

      Farhat Nasim14 July 2019 10:15 AM IST
      Aurobindo Pharma's Cinacalcet Hydrochloride tablets 30mg, 60mg, and 90mg is a generic version of Amgen Inc's Sensipar tablets, Cinacalcet...
      Dr Reddys gets 5 USFDA observations for Bollaram plant

      Dr Reddys gets 5 USFDA observations for Bollaram plant

      Farhat Nasim13 July 2019 12:25 PM IST
      "The audit of our active pharmaceutical ingredient (API) manufacturing plant 2 at Bollaram, Hyderabad by the United States Food and Drug...
      CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

      CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

      Farhat Nasim11 July 2019 5:38 PM IST
      New Delhi: The Swiss drugmaker, Novartis recently presented before the Central Drugs Standard Control Organization(CDSCO) Technical Committee to seek...
      HealthAssure raises over Rs 17 crore in Series A funding led by Blume Ventures

      HealthAssure raises over Rs 17 crore in Series A funding led by Blume Ventures

      Farhat Nasim11 July 2019 11:59 AM IST
      HealthAssure will use the funds to augment its platform, create sharper products that serve the various primary care needs more effectively including...
      Fortis ​Healthcare divests 28 percent stake in Mauritius-based Medical and Surgical Centre

      Fortis ​Healthcare divests 28 percent stake in Mauritius-based Medical and Surgical Centre

      Farhat Nasim10 July 2019 11:12 AM IST
      Fortis has 28.89 per cent stake in MSCL while its Mauritius-based partner CIEL Healthcare holds 58.6 per cent. The rest is held by other shareholders....
      Difference of 50-90 percent in prices of Branded and Generic medicines- Minister informs Parliament

      Difference of 50-90 percent in prices of Branded and Generic medicines- Minister informs Parliament

      Farhat Nasim9 July 2019 4:13 PM IST
      New Delhi: Through a recent reply, the Minister in the Ministry of Chemical and Fertilizers has informed the Parliament about the difference between...
      Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details

      Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details

      Farhat Nasim8 July 2019 4:16 PM IST
      New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
      Biocon gets dozen USFDA observations for 3 units in Malaysia

      Biocon gets dozen USFDA observations for 3 units in Malaysia

      Farhat Nasim8 July 2019 4:08 PM IST
      Biocon Sdn Bhd's insulin glargine drug substance, drug product and device assembly facilities in Malaysia underwent a pre-approval inspection by the...
      Licenses of over 50 chemist shops scrapped for Running without pharmacist

      Licenses of over 50 chemist shops scrapped for Running without pharmacist

      Farhat Nasim7 July 2019 5:05 PM IST
      Agra: Coming down heavily on chemist stores functioning without a pharmacist, the district drug administration has recently cancelled licenses of over...
      Classifying ENDS devices as DRUGS: Health Ministry asks Attorney General to Opine

      Classifying ENDS devices as DRUGS: Health Ministry asks Attorney General to Opine

      Farhat Nasim7 July 2019 10:00 AM IST
      Banning alternative smoking devices like e-cigarettes, heat-not-burn devices, vape and e-nicotine flavoured hookah is one of the priorities of the...
      Definition of generic drugs discussed in Parliament

      Definition of generic drugs discussed in Parliament

      Farhat Nasim7 July 2019 9:50 AM IST
      He said that the generic medicines are generally those which contain some amount of same active ingredients in same dosage form, and are intended to...
      Japanese medical equipment firm Nemoto Kyorindo plans to invest in Punjab

      Japanese medical equipment firm Nemoto Kyorindo plans to invest in Punjab

      Farhat Nasim6 July 2019 9:30 AM IST
      The Japanese firm is one of the world's leading producers of surgical tables, contrast agent injectors, and specialises in the field of medical image...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok